<DOC>
	<DOCNO>NCT00732537</DOCNO>
	<brief_summary>Inhaled nitric oxide ( iNO ) improve oxygenation term infant respiratory failure . However , iNO primarily use infant receive mechanical ventilation . This study pilot study determine iNO give oxygen hood effective improve oxygenation term near-term infant poor oxygenation yet mechanically ventilate .</brief_summary>
	<brief_title>Inhaled Nitric Oxide Oxygen Hood Neonates</brief_title>
	<detailed_description>Inhaled nitric oxide ( iNO ) currently use management ventilate neonate hypoxemic respiratory failure . We show iNO administer oxygen hood reduces pulmonary vascular resistance hypoxia- group B streptococcus-induced pulmonary hypertension animal model ( J Perinatol 2002 ; 22:50-6 ) . Our objective determine feasibility iNO administration oxygen hood neonate respiratory failure . Methods : A masked randomized control trial perform eight infant respiratory failure . Inclusion criterion : gestation &gt; 34 week , age &lt; 7 day , post-ductal arterial line , A-aDO2 400-600 two consecutive blood gas . Infants randomize study gas ( iNO 20 ppm equivalent flow O2 ) 1 hr wean next 4 hour . The iNO introduce oxygen hood use INOvent ( INO Therapeutics , Inc ) . The primary outcome PaO2 one hour randomization . Environmental leakage NO NO2 measure . Results : Four infant randomize iNO four O2 ( control ) . Two four infant give iNO increase PaO2 &gt; 100 mm Hg , oxygenation unchanged control . Methemoglobinemia adverse effect note infant . Environmental level NO NO2 minimal ( &lt; 1ppm ) undetectable &gt; 0.3m hood . Conclusions : Administration iNO oxygen hood feasible . Larger randomize control trial require measure efficacy determine appropriate target population technique .</detailed_description>
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<mesh_term>Persistent Fetal Circulation Syndrome</mesh_term>
	<mesh_term>Nitric Oxide</mesh_term>
	<criteria>gestation &gt; 34 week birth age &lt; 7 day postductal arterial line AaDO2 400 600 two blood gas , least 30 minute apart . Infants major malformation Infants cardiac disease</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>1 Week</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>Hypoxia</keyword>
	<keyword>Respiratory failure</keyword>
	<keyword>Infant , term</keyword>
	<keyword>Nitric oxide</keyword>
</DOC>